MOLLY DALE: Open Payments
NPI 1427788470 · DEAL ISLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 16 payments from 10 companies in 2025. Trend: 2023 $120 · 2024 $306 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $173 |
| Lilly USA, LLC | 3 | $59 |
| ABBVIE INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Ortho-Clinical Diagnostics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: Epclusa, ZEPBOUND, Cologuard Collection Kit, Auvelity, MAVYRET, MOUNJARO, QULIPTA, REXULTI.
Industry payments across MD — which companies pay providers there.
